Cytidine deaminase genetic variants influence RNA expression and cytarabine cytotoxicity in acute myeloid leukemia

Author： Abraham Ajay   Varatharajan Savitha   Abbas Salar   Zhang Wei   Shaji Ramachandran V   Ahmed Rayaz   Abraham Aby   George Biju   Srivastava Alok   Chandy Mammen   Mathews Vikram   Balasubramanian Poonkuzhali  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.3, 2012-02, pp. : 269-282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Acute Myeloid Leukemia

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 10, 2008-11 ,pp. : 962-962

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Pharmacogenomics in acute myeloid leukemia

By Roumier Christophe   Cheok Meyling H  

Pharmacogenomics, Vol. 10, Iss. 11, 2009-11 ,pp. : 1839-1851

Future Medicine

Access to resources Recommend Favorite

Immunotherapy in acute myeloid leukemia

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2689-2704

Blackwell Publishing

Access to resources Recommend Favorite

Immunotherapy of Acute Myeloid Leukemia

By  

Current Pharmaceutical Biotechnology, Vol. 2, Iss. 3, 2001-09 ,pp. : 209-215

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Expression Profiling as a Diagnostic Tool in Acute Myeloid Leukemia

By Wolfgang Kern   Alexander Kohlmann   Susanne Schnittger   Wolfgang Hiddemann   Claudia Schoch   Torsten Haferlach  

American Journal of PharmacoGenomics, Vol. 4, Iss. 4, 2004-01 ,pp. : 225-237

Adis International

Access to resources Recommend Favorite